Solmaz Sahebjam MD
Hematologic Oncology, Neuro-Oncology
Director of Neuro-oncology Program in National Capital Region at Johns Hopkins Sidney Kimmel Cancer Center, Deputy Director of Clinical Research in National Capital Region at Johns Hopkins Sidney Kimmel Cancer Center, Associate Professor of Oncology at Johns Hopkins School of Medicine
Join to view full profile
5255 Loughboro Road NorthwestBuilding BWashington, DC 20016
Phone+1 202-660-6500
Fax+1 202-660-6501
Dr. Sahebjam is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
St Vincent HospitalResidency, Internal Medicine, 2006 - 2008
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 2005 - 2006
Iran University of Medical SciencesClass of 2000
Certifications & Licensure
DC State Medical License 2022 - 2027
MD State Medical License 2023 - 2027
FL State Medical License 2013 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Royal College of Physicians and Surgeons of CanadaBoard of Internal Medicine- Royal College of Physicians and Surgeons of CanadaBoard of Medical Oncology
Clinical Trials
- A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients Start of enrollment: 2014 Feb 07
- Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
- Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction Start of enrollment: 2014 Mar 10
Publications & Presentations
PubMed
- ALT phenotype assessment in IDH-mutant astrocytoma supports biologic consequence of ATRX missense mutations.Oguzhan O Kizilkaya, Kevin Y Zhang, Mohamed Sherief, Debraj Mukherjee, Chetan Bettegowda
Brain Pathology. 2026-07-24 - Unique Peritumoral Patterns Unveiled by Quantitative Multiparametric MRI and Their Diagnostic and Prognostic Value in Treated Malignant Gliomas.Keyi Chai, Puyang Wang, Austin Carmichael, Jingpu Wu, Zongpai Zhang
NMR in Biomedicine. 2026-06-01 - 1 citationsIntracranial metastases from solid tumors: Call to action and consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology collaborative.Akanksha Sharma, Lucy Boyce Kennedy, Amanda E D Van Swearingen, Manmeet S Ahluwalia, Stephen J Bagley
Neuro-Oncology. 2026-02-01
Journal Articles
- Effect of Nivolumab vs Bevacizumab in Patients with Recurrent GlioblastomaDavid A Reardon, Antonio Omuro, Joachim Baehring, Surasak Phuphanich, Solmaz Sahebjam, JAMA Oncology
Authored Content
- Effect of Nivolumab vs Bevacizumab in Patients with Recurrent GlioblastomaMay 2020
- Effect of Nivolumab vs Bevacizumab in Patients with Recurrent GlioblastomaMay 2020
- Effect of Nivolumab vs Bevacizumab in Patients with Recurrent GlioblastomaMay 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
